MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

Author:

Vannice Kirsten S,Brown Graham V,Akanmori Bartholomew D,Moorthy Vasee S

Abstract

Abstract The World Health Organization (WHO) convened a malaria vaccines committee (MALVAC) scientific forum from 20 to 21 February 2012 in Geneva, Switzerland, to review the global malaria vaccine portfolio, to gain consensus on approaches to accelerate second-generation malaria vaccine development, and to discuss the need to update the vision and strategic goal of the Malaria Vaccine Technology Roadmap. This article summarizes the forum, which included reviews of leading Plasmodium falciparum vaccine candidates for pre-erythrocytic vaccines, blood-stage vaccines, and transmission-blocking vaccines. Other major topics included vaccine candidates against Plasmodium vivax, clinical trial site capacity development in Africa, trial design considerations for a second-generation malaria vaccine, adjuvant selection, and regulatory oversight functions including vaccine licensure.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Reference11 articles.

1. Malaria Vaccine Technology Roadmap: http://www.malariavaccine.org/files/Malaria_Vaccine_TRM_Final.pdf.

2. World Health Organization:Most advanced malaria vaccine candidate and timing for policy recommendations. http://www.who.int/vaccine_research/diseases/malaria/vaccine_candidate_policy/en/index.html.,

3. malERA:A research agenda for malaria eradication. PLoS Med. 2011, 8 (1): 1-99.

4. Laurens MB, Roestenberg M, Moorthy VS, The Consensus Group on Design of Clinical Trials of Controlled Human Malaria Infection: A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines. Vaccine. 2012, 30 (36): 5302-5304. 10.1016/j.vaccine.2012.04.088.

5. World Health Organization: NIAID/WHO Workshop on Heterologous Prime-Boost Strategies for HIV, Malaria and Tuberculosis Vaccines. http://www.who.int/vaccine_research/diseases/malaria/niaid_workshop_hiv_malaria_tb_2012/en/index.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3